Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors.

Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B.

Onco Targets Ther. 2016 May 10;9:2769-81. doi: 10.2147/OTT.S99242.

2.

Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.

Kaluzova M, Bouras A, Machaidze R, Hadjipanayis CG.

Oncotarget. 2015 Apr 20;6(11):8788-806.

3.

Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.

Hiramatsu R, Kawabata S, Tanaka H, Sakurai Y, Suzuki M, Ono K, Miyatake S, Kuroiwa T, Hao E, Vicente MG.

J Pharm Sci. 2015 Mar;104(3):962-70. doi: 10.1002/jps.24317.

4.

Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding protein.

van Dongen MA, Rattan R, Silpe J, Dougherty C, Michmerhuizen NL, Van Winkle M, Huang B, Choi SK, Sinniah K, Orr BG, Banaszak Holl MM.

Mol Pharm. 2014 Nov 3;11(11):4049-58. doi: 10.1021/mp500608s.

5.

Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues.

Madaan K, Kumar S, Poonia N, Lather V, Pandita D.

J Pharm Bioallied Sci. 2014 Jul;6(3):139-50. doi: 10.4103/0975-7406.130965. Review.

6.

Multifunctional nanoparticles for brain tumor imaging and therapy.

Cheng Y, Morshed RA, Auffinger B, Tobias AL, Lesniak MS.

Adv Drug Deliv Rev. 2014 Feb;66:42-57. doi: 10.1016/j.addr.2013.09.006. Review.

7.

Therapeutic nanomedicine for brain cancer.

Tzeng SY, Green JJ.

Ther Deliv. 2013 Jun;4(6):687-704. doi: 10.4155/tde.13.38. Review.

8.

Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.

Thomas TP, Joice M, Sumit M, Silpe JE, Kotlyar A, Bharathi S, Kukowska-Latallo J, Baker JR, Choi SK.

Curr Pharm Des. 2013;19(37):6594-605.

9.

Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass.

Bartell SM, Han L, Kim HN, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS, Chambliss KL, Shaul PW, Roberson PK, Weinstein RS, Jilka RL, Almeida M, Manolagas SC.

Mol Endocrinol. 2013 Apr;27(4):649-56. doi: 10.1210/me.2012-1368.

10.

Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.

Choi SK, Thomas TP, Li MH, Desai A, Kotlyar A, Baker JR Jr.

Photochem Photobiol Sci. 2012 Apr;11(4):653-60. doi: 10.1039/c2pp05355a.

11.

Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Li MH, Choi SK, Thomas TP, Desai A, Lee KH, Kotlyar A, Banaszak Holl MM, Baker JR Jr.

Eur J Med Chem. 2012 Jan;47(1):560-72. doi: 10.1016/j.ejmech.2011.11.027.

12.

Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.

Peng XH, Wang Y, Huang D, Wang Y, Shin HJ, Chen Z, Spewak MB, Mao H, Wang X, Wang Y, Chen ZG, Nie S, Shin DM.

ACS Nano. 2011 Dec 27;5(12):9480-93. doi: 10.1021/nn202410f.

13.

Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiography.

Nwe K, Milenic DE, Ray GL, Kim YS, Brechbiel MW.

Mol Pharm. 2012 Mar 5;9(3):374-81. doi: 10.1021/mp2003219.

14.

Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.

Mullen DG, McNerny DQ, Desai A, Cheng XM, Dimaggio SC, Kotlyar A, Zhong Y, Qin S, Kelly CV, Thomas TP, Majoros I, Orr BG, Baker JR, Banaszak Holl MM.

Bioconjug Chem. 2011 Apr 20;22(4):679-89. doi: 10.1021/bc100360v.

15.

Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.

Liu J, Liu J, Chu L, Wang Y, Duan Y, Feng L, Yang C, Wang L, Kong D.

Int J Nanomedicine. 2010 Dec 22;6:59-69. doi: 10.2147/IJN.S14601.

16.

Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Yuan Q, Lee E, Yeudall WA, Yang H.

Oral Oncol. 2010 Sep;46(9):698-704. doi: 10.1016/j.oraloncology.2010.07.001.

17.

Electrophoretic Behavior of Anionic Triazine and PAMAM Dendrimers: Methods for Improving Resolution and Assessing Purity Using Capillary Electrophoresis.

Lalwani S, Venditto VJ, Chouai A, Rivera GE, Shaunak S, Simanek EE.

Macromolecules. 2009 Apr 28;42(8):3152-3161.

18.

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb.

Shukla R, Thomas TP, Desai AM, Kotlyar A, Park SJ, Baker JR.

Nanotechnology. 2008 Jul 23;19(29):295102. doi: 10.1088/0957-4484/19/29/295102.

19.

Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.

Yang H.

Pharm Res. 2010 Sep;27(9):1759-71. doi: 10.1007/s11095-010-0141-7. Review.

20.

Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW.

J Clin Invest. 2010 Jul;120(7):2319-30. doi: 10.1172/JCI38291.

Supplemental Content

Support Center